Calidi Biotherapeutics's total assets for Q1 2024 were $7.41M, a decrease of -26.09% from the previous quarter. CLDI total liabilities were $21.98M for the fiscal quarter, a 20.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.